ClinicalTrials.Veeva

Menu

Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.

F

Fundación Universidad Católica de Valencia San Vicente Mártir

Status

Enrolling

Conditions

SARS CoV 2 Infection
Migraine Disorders
Chronic Pain
Persistent COVID-19
Headaches Chronic
Cluster Headache
Long Covid19
COVID-19
Post COVID-19 Condition
Myalgia
Long COVID
Post-COVID-19 Syndrome
Arthralgia

Treatments

Device: Transcranial Direct Current Therapy (tDCS)

Study type

Interventional

Funder types

Other

Identifiers

NCT05780450
UCV/2021-2022/140

Details and patient eligibility

About

This study aims to verify the efficacy / effectiveness of treatment with transcranial direct therapy (TDCS) in patients with Persistent Covid who present headaches, migraines and chronic pain, such as arthralgias and myalgias.

Transcranial Direct Therapy is used in the field of Physiotherapy and Rehabilitation, with results that prove to be effective for the treatment of patients suffering from symptoms such as migraines, headaches, chronic pain, fibromyalgia or chronic neuropathic pain.

As can be seen, in the case of patients with Persistent Covid we find several of these symptoms, so it is suggested that, if Transcranial Direct Current Therapy (TDCs) is giving such good results, relieving these symptoms, why can not give such good results and help so much in patients with Persistent Covid, If many of the symptoms are the same, even if the origin or cause is different.

Enrollment

27 estimated patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Persistent Covid
  • Men and women
  • All ages from 16 years old
  • Patients who passed the Covid in its acute phase in an asymptomatic, mild and severe way.

Exclusion criteria

  • Patients without confirmation with positive PCR in the acute phase of Covid-19
  • Patients with Persistent Covid who do not have at least one of these symptoms: migraines, headaches, chronic pain, neuropathic pain, arthralgia, myalgias
  • Patients with pacemaker / defibrillator
  • Patients with brain implants
  • Patients with cranial fractures
  • Pregnant

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

27 participants in 1 patient group

Treatment group
Experimental group
Treatment:
Device: Transcranial Direct Current Therapy (tDCS)

Trial contacts and locations

2

Loading...

Central trial contact

LAURA GARCÍA MARTÍNEZ

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems